US 11278592
Methods and compositions for TUSC2 immunotherapy
granted A61KA61K2039/505A61K38/1709
Quick answer
US patent 11278592 (Methods and compositions for TUSC2 immunotherapy) held by The Board of Regents of the University of Texas System expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K38/1709, A61K39/39541, A61K45/06